Skip to main content
13449 Suchergebnisse für:

Helicobacter pylori 

sortieren nach |
"Aktualität" sortiert die Ergebnisse nach Publikationsdatum. "Relevanz" berücksichtigt auch noch andere Faktoren wie zum Beispiel die Häufigkeit der Suchbegriffe im Text.
  1. Open Access 01.03.2024 | Letter

    Non-Helicobacter pylori Helicobacter Species as a Cause of Refractory Chronic Cellulitis in X-Linked Agammaglobulinemia

    A 17-year-old boy was admitted to our Department due to a 5-year history of skin infections. He lived in a rural area, and his family raised pigs in the yard. There was no family history of immunodeficiency. He developed perianal abscess at 3 …

  2. Open Access 01.12.2024 | OriginalPaper

    Effect of concurrent infection of Helicobacter pylori with Toxoplasma gondii infection on gastric pathology

    Infectious diseases incorporate a wide range of conditions that significantly threaten the health of humans [ 26 ].. Humans are commonly infected with multiple pathogens simultaneously or consecutively, and synergistic and antagonistic pathogenic …

  3. 23.02.2024 | ReviewPaper

    Vonoprazan: A Review in Helicobacter pylori Infection

    Treatment for the eradication of Helicobacter pylori infection, a leading cause of peptic ulcer disease and an important risk factor for gastric cancer and mucosa-associated lymphoid tissue lymphoma, is indicated whenever infection is identified.

  4. Open Access 01.12.2024 | OriginalPaper

    The association between Helicobacter pylori infection and the risk for gout in hyperuricemia patients in China – A cross-sectional study

    Helicobacter pylori ( H. pylori ) is a gram-negative spiral bacterium that colonizes in the gastric mucosa persistently, infecting approximately 4.4 billion people worldwide and varying considerably according to geographic region [ 1 ]. H. pylori

  5. Open Access 24.02.2024 | OriginalPaper

    Effects of Preoperative Quadruple Therapy for Helicobacter pylori on Bariatric Surgery Metabolic Outcomes

    Bariatric surgery (BS) is a recognized long-term treatment for severe obesity [ 1 , 2 ], with improvement in associated comorbidities such as type 2 diabetes, hypertension, dyslipidemia, and sleep apnea [ 3 ]. In recent years, comorbidity recovery …

  6. 15.02.2024 | Letter

    The Impact of Helicobacter pylori on Laparoscopic Sleeve Gastrectomy Postoperative Complications: Insights and Limitations

  7. 15.03.2024 | Online First

    Association of Helicobacter Pylori in Chronic Tonsillitis

    The objective of the study was to detect the presence of Helicobacter pylori in adenotonsillar tissue and to assess the association between the presence of H pylori with Chronic Tonsillitis or Adenotonsillitis. This was a cross sectional study …

  8. 15.02.2024 | OriginalPaper

    Influence of Helicobacter pylori Infection and Eradication on Small Intestinal Bacterial Overgrowth and Abdominal Symptoms

    Helicobacter pylori ( H. pylori ) is a Gram-negative bacterium involved in the development of several gastric and extragastric diseases, such as gastritis, peptic ulcer, gastric malignancies, sideropenic anemia, and idiopathic thrombocytopenic …

  9. Open Access 01.12.2024 | OriginalPaper

    Causal association between helicobacter pylori and atherosclerosis: a two-sample Mendelian randomization

    Despite the fact Helicobacter pylori (H. pylori) is mostly innocuous and most infected people show no symptoms, infection has been connected to numerous illnesses, including peptic ulcer disease, nonulcer dyspepsia, and even cancer. The global H.

  10. 10.04.2024 | Online First

    Estimates of global and regional prevalence of Helicobacter pylori infection among individuals with obesity: a systematic review and meta-analysis

    Given the potential for transmission and the significant complications that can arise, particularly in individuals with chronic infections, the prevalence of Helicobacter pylori ( H. pylori ) infection and its association with host and …

  11. Open Access 01.12.2024 | OriginalPaper

    Prevalence of Helicobacter pylori infection and effectiveness of first-line triple eradication therapy among dyspeptic patients at hospitals in Hawassa City, Ethiopia: a cross-sectional follow-up study

    Dyspepsia is a complex disorder with several distinct pathophysiologic mechanisms. 70% of cases of dyspepsia are classified as functional dyspepsia (FD), which is characterized as epigastric discomfort (postprandial fullness, early satiety, and …

  12. 25.01.2024 | ReviewPaper

    Infiltration to infection: key virulence players of Helicobacter pylori pathogenicity

    Helicobacter pylori ( H. pylori ) is a microaerophilic, Gram-negative bacterium that colonises the inner lining of the gastric epithelial cells in the stomach. Since its discovery in 1983, it has become a global health concern owing to increased …

  13. Open Access 23.03.2024 | Online First

    Verrucous gastritis-like lesion in intramucosal Helicobacter pylori-uninfected signet ring cell carcinoma with poorly differentiated adenocarcinoma

    In Japan, accessible Helicobacter pylori (Hp) eradication therapy is associated with an increase in the prevalence of gastric cancers (GCs) in Hp uninfected stomachs. Signet ring cell carcinoma (SRCC) is the most common of these GCs. Intramucosal …

  14. Open Access 01.12.2024 | OriginalPaper

    Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial

    Helicobacter pylori (Hp) is a pathogen that primarily resides in the stomach and infects nearly half of the world’s population [ 1 ]. In China, the prevalence of Hp infection is approximately 40% [ 2 ]. Most people with Hp infection may not display …

  15. Open Access 02.11.2023 | ReviewPaper

    Helicobacter pylori and oral–gut microbiome: clinical implications

    More than half of the world’s population are colonized with H. pylori; however, the prevalence varies geographically with the highest incidence in Africa. H. pylori is probably a commensal organism that has been associated with the development of …

  16. 26.02.2024 | OriginalPaper

    Gastric fundic gland polyposis and cancer development after eradication of Helicobacter pylori in patient with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS)

    A 44-year-old woman with gastric cancer (GC) and fundic gland polyposis (FGPs) was referred to our hospital for further diagnosis and treatment. She successfully underwent eradication therapy for Helicobacter pylori (HP) 6 years ago, but did not …

  17. 10.02.2024 | ReviewPaper

    Helicobacter pylori Eradication Treatment in Older Patients

    Helicobacter pylori is the main etiopathogenetic factor of chronic gastritis, peptic ulcer disease and gastric cancer. The world’s population is shifting towards older people, who have the highest prevalence of H. pylori. Aging-related …

  18. Open Access 01.02.2024 | OriginalPaper

    Helicobacter pylori upregulates circPGD and promotes development of gastric cancer

    Gastric cancer, also known as stomach cancer, is a relatively common malignancy, being the third most common cause of cancer-related deaths worldwide (Lu et al. 2022 ; Ma et al. 2022 ). With a relative five-year survival rate below 30% in its …

  19. 11.12.2023 | OriginalPaper

    Comparison of weight loss after Roux-en-Y gastric bypass in Helicobacter pylori-negative and Helicobacter pylori eradicated patients during five years follow-ups

    This retrospective cohort study was conducted on 305 patients with age 18 and more with severe obesity (BMI ≥ 40 kg/m 2 or BMI ≥ 35 kg/m 2 with at least an obesity-associated medical problem), who underwent primary RYGB from February 2014 to …

  20. 14.02.2024 | Letter

    Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial

Suchergebnisse filtern:

e.Medpedia

Helicobacter pylori

Lexikon der Medizinischen Laboratoriumsdiagnostik

weitere e.Medpedia Einträge

Suchoperatoren:

„ ... ... “ Findet Dokumente mit genau dieser Wortgruppe in exakt dieser Schreibweise und Reihenfolge (z.B., "rheumatische Beschwerden").
AND / UND Findet Dokumente, in denen beide Begriffe zusammen vorkommen (z.B., alkohol UND demenz).
OR / ODER Findet Dokumente, in denen einer der beiden oder beide Begriffe vorkommen (z.B., hiv ODER aids).
Leerzeichen Findet Dokumente, in denen alle Begriffe vorkommen. Der Leerschritt wird als UND interpretiert (z.B., isolierte systolische hypertonie).
NOT / NICHT Findet Dokumente, in denen der Begriff nach NOT nicht vorkommt (z.B., sars NOT sars-cov-2).
COUNT(...)>n Findet Dokumente, in denen der gesuchte Begriff mehr als n mal vorkommt. n steht für eine beliebige Anzahl (z.B., COUNT(mammakarzinom)>8).
NEAR(..., ..., ) Findet Dokumente, in denen beide Begriffe in beliebiger Reihenfolge innerhalb von maximal n Worten zueinander stehen. Empfehlung: wählen Sie zwischen 15 und 30 als maximale Wortanzahl (z.B., NEAR(covid, diabetes,20)).
* Findet Dokumente, in denen der Begriff in Wortvarianten vorkommt, wobei diese VOR, HINTER oder VOR und HINTER dem Suchbegriff anschließen können (z.B., thrombose*, *thrombose, *thrombose*).
? Findet Dokumente mit dem Suchbegriff in verschiedenen Schreibweisen, hier mit s oder z, also organisation und organization. Das ? steht für eine einzige Stelle (z.B., organi?ation).
& + - Sonderzeichen werden als UND interpretiert (z.B., Diagnose + Therapie).

Sie können Operatoren mit Ihrer Suchanfrage kombinieren, um diese noch präziser einzugrenzen.

Fahren Sie mit der Maus über den Suchoperator, um eine Erklärung seiner Funktionsweise anzuzeigen.